Earnings came to $7.22 a share, up from $6.21 a year earlier, with weight loss drugs leading the gains, per The Wall Street Journal.
Recap by typeshit. Full story at The Wall Street Journal.
BuzzFeed notes these medications have helped people worldwide, pro athletes among them, with weight, appetite and blood sugar control.
Novo Nordisk's weight loss drug brand is the presenting sponsor of the playoff game, airing at 4:30 PM ET on TSN, RDS and CFL+.
Novo Nordisk's Wegovy puts its name on the October 31 playoff game in Canada, airing at 4:30 PM ET on TSN, RDS and CFL+.
A doctor writes about a 45-year-old woman without diabetes who came in for obesity treatment, opening a column on how such patients are handled.
He shares a short clip on why he started a GLP-1 and what it has been like, and points to a longer YouTube video that goes deeper.
Mounjaro brought in $10.7 billion and Zepbound $5.4 billion in Q3. Lilly also reported retatrutide Phase 3 data showing 20.9% weight loss versus 9.4% on Ozempic.
Loading…